UniProt ID | M2OM_HUMAN | |
---|---|---|
UniProt AC | Q02978 | |
Protein Name | Mitochondrial 2-oxoglutarate/malate carrier protein | |
Gene Name | SLC25A11 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 314 | |
Subcellular Localization |
Mitochondrion inner membrane Multi-pass membrane protein . |
|
Protein Description | Catalyzes the transport of 2-oxoglutarate across the inner mitochondrial membrane in an electroneutral exchange for malate or other dicarboxylic acids, and plays an important role in several metabolic processes, including the malate-aspartate shuttle, the oxoglutarate/isocitrate shuttle, in gluconeogenesis from lactate, and in nitrogen metabolism (By similarity). Maintains mitochondrial fusion and fission events, and the organization and morphology of cristae. [PubMed: 21448454 Involved in the regulation of apoptosis (By similarity] | |
Protein Sequence | MAATASAGAGGIDGKPRTSPKSVKFLFGGLAGMGATVFVQPLDLVKNRMQLSGEGAKTREYKTSFHALTSILKAEGLRGIYTGLSAGLLRQATYTTTRLGIYTVLFERLTGADGTPPGFLLKAVIGMTAGATGAFVGTPAEVALIRMTADGRLPADQRRGYKNVFNALIRITREEGVLTLWRGCIPTMARAVVVNAAQLASYSQSKQFLLDSGYFSDNILCHFCASMISGLVTTAASMPVDIAKTRIQNMRMIDGKPEYKNGLDVLFKVVRYEGFFSLWKGFTPYYARLGPHTVLTFIFLEQMNKAYKRLFLSG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAATASAGA ------CCCCCCCCC | 17.33 | 19413330 | |
4 | Phosphorylation | ----MAATASAGAGG ----CCCCCCCCCCC | 16.17 | 25850435 | |
6 | Phosphorylation | --MAATASAGAGGID --CCCCCCCCCCCCC | 23.92 | 29255136 | |
15 | Ubiquitination | GAGGIDGKPRTSPKS CCCCCCCCCCCCHHH | 27.81 | - | |
15 | Acetylation | GAGGIDGKPRTSPKS CCCCCCCCCCCCHHH | 27.81 | 21339330 | |
18 (in isoform 2) | Phosphorylation | - | 58.89 | 25056879 | |
18 | Phosphorylation | GIDGKPRTSPKSVKF CCCCCCCCCHHHHHH | 58.89 | 22199227 | |
19 (in isoform 2) | Phosphorylation | - | 31.45 | 25056879 | |
19 | Phosphorylation | IDGKPRTSPKSVKFL CCCCCCCCHHHHHHH | 31.45 | 22199227 | |
22 | Phosphorylation | KPRTSPKSVKFLFGG CCCCCHHHHHHHHCC | 33.64 | - | |
33 | Sulfoxidation | LFGGLAGMGATVFVQ HHCCCCCCCCEEEEE | 2.48 | 28183972 | |
34 (in isoform 2) | Phosphorylation | - | 19.71 | - | |
34 | Phosphorylation | FGGLAGMGATVFVQP HCCCCCCCCEEEEEE | 19.71 | - | |
52 | Phosphorylation | VKNRMQLSGEGAKTR HHHHHHHCCCCCCCH | 20.22 | 21406692 | |
57 | 2-Hydroxyisobutyrylation | QLSGEGAKTREYKTS HHCCCCCCCHHHHHH | 60.00 | - | |
57 | Ubiquitination | QLSGEGAKTREYKTS HHCCCCCCCHHHHHH | 60.00 | 21890473 | |
57 | Succinylation | QLSGEGAKTREYKTS HHCCCCCCCHHHHHH | 60.00 | 21890473 | |
57 | Succinylation | QLSGEGAKTREYKTS HHCCCCCCCHHHHHH | 60.00 | - | |
62 | Ubiquitination | GAKTREYKTSFHALT CCCCHHHHHHHHHHH | 32.70 | 21890473 | |
63 | Phosphorylation | AKTREYKTSFHALTS CCCHHHHHHHHHHHH | 35.41 | 27050516 | |
64 | Phosphorylation | KTREYKTSFHALTSI CCHHHHHHHHHHHHH | 15.75 | 27050516 | |
69 | Phosphorylation | KTSFHALTSILKAEG HHHHHHHHHHHHHCC | 17.95 | 27050516 | |
70 | Phosphorylation | TSFHALTSILKAEGL HHHHHHHHHHHHCCC | 27.12 | 27050516 | |
73 | Ubiquitination | HALTSILKAEGLRGI HHHHHHHHHCCCCHH | 42.60 | 73 | |
73 | Acetylation | HALTSILKAEGLRGI HHHHHHHHHCCCCHH | 42.60 | 19608861 | |
78 | Methylation | ILKAEGLRGIYTGLS HHHHCCCCHHHHHHC | 40.08 | 115917065 | |
95 | Phosphorylation | LLRQATYTTTRLGIY HHHHCCCCCHHHCHH | 19.82 | 26437602 | |
102 | Phosphorylation | TTTRLGIYTVLFERL CCHHHCHHHHHHHHH | 6.76 | 25147952 | |
103 | Phosphorylation | TTRLGIYTVLFERLT CHHHCHHHHHHHHHH | 14.60 | 22673903 | |
115 | Phosphorylation | RLTGADGTPPGFLLK HHHCCCCCCCCHHHH | 27.19 | 24641631 | |
127 | Sulfoxidation | LLKAVIGMTAGATGA HHHHHHCCCCCCCCC | 1.27 | 28183972 | |
161 | Phosphorylation | PADQRRGYKNVFNAL CHHHHHCHHHHHHHH | 9.51 | - | |
162 | Ubiquitination | ADQRRGYKNVFNALI HHHHHCHHHHHHHHH | 49.84 | 21890473 | |
201 | Phosphorylation | VNAAQLASYSQSKQF HCHHHHHHHHCCCCH | 33.63 | 28152594 | |
202 | Phosphorylation | NAAQLASYSQSKQFL CHHHHHHHHCCCCHH | 12.72 | 28152594 | |
203 | Phosphorylation | AAQLASYSQSKQFLL HHHHHHHHCCCCHHH | 26.03 | 28152594 | |
205 | Phosphorylation | QLASYSQSKQFLLDS HHHHHHCCCCHHHHC | 23.60 | 28152594 | |
256 | Succinylation | NMRMIDGKPEYKNGL HCEEECCCCCCCCCH | 30.81 | 23954790 | |
256 | Acetylation | NMRMIDGKPEYKNGL HCEEECCCCCCCCCH | 30.81 | - | |
256 | Ubiquitination | NMRMIDGKPEYKNGL HCEEECCCCCCCCCH | 30.81 | - | |
303 | Sulfoxidation | TFIFLEQMNKAYKRL HHHHHHHHHHHHHHH | 3.97 | 28183972 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of M2OM_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of M2OM_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of M2OM_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
COPA_HUMAN | COPA | physical | 16169070 | |
M2OM_HUMAN | SLC25A11 | physical | 8597574 | |
POTEI_HUMAN | POTEI | physical | 26186194 | |
ACTBL_HUMAN | ACTBL2 | physical | 26186194 | |
YTHD1_HUMAN | YTHDF1 | physical | 26186194 | |
FYN_HUMAN | FYN | physical | 26186194 | |
YES_HUMAN | YES1 | physical | 26186194 | |
PPR1A_HUMAN | PPP1R1A | physical | 26186194 | |
REN3B_HUMAN | UPF3B | physical | 26186194 | |
SMAP2_HUMAN | SMAP2 | physical | 26186194 | |
KPCA_HUMAN | PRKCA | physical | 26186194 | |
ZN703_HUMAN | ZNF703 | physical | 26186194 | |
WIPI4_HUMAN | WDR45 | physical | 26186194 | |
PRG2_HUMAN | PRG2 | physical | 26186194 | |
VDAC1_HUMAN | VDAC1 | physical | 26344197 | |
VDAC2_HUMAN | VDAC2 | physical | 26344197 | |
VDAC3_HUMAN | VDAC3 | physical | 26344197 | |
POTEI_HUMAN | POTEI | physical | 28514442 | |
PPR1A_HUMAN | PPP1R1A | physical | 28514442 | |
SMAP2_HUMAN | SMAP2 | physical | 28514442 | |
ACTBL_HUMAN | ACTBL2 | physical | 28514442 | |
YTHD1_HUMAN | YTHDF1 | physical | 28514442 | |
PRG2_HUMAN | PRG2 | physical | 28514442 | |
WIPI4_HUMAN | WDR45 | physical | 28514442 | |
ACTB_HUMAN | ACTB | physical | 28514442 | |
YES_HUMAN | YES1 | physical | 28514442 | |
ZN703_HUMAN | ZNF703 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-73, AND MASS SPECTROMETRY. |